Intrahepatic Lipid Content and Insulin Resistance Are More Strongly Associated with Impaired NEFA Suppression after Oral Glucose Loading Than with Fasting NEFA Levels in Healthy Older Individuals

Introduction. The mechanisms underlying the association between insulin resistance and intrahepatic lipid (IHL) accumulation are not completely understood. We sought to determine whether this association was explained by differences in fasting non-esterified fatty acid (NEFA) levels and/or NEFA suppression after oral glucose loading. Materials and Methods. We performed a cross-sectional analysis of 70 healthy participants in the Hertfordshire Physical Activity Trial (39 males, age 71.3 ± 2.4 years) who underwent oral glucose tolerance testing with glucose, insulin, and NEFA levels measured over two hours. IHL was quantified with magnetic resonance spectroscopy. Insulin sensitivity was measured with the oral glucose insulin sensitivity (OGIS) model, the leptin: adiponectin ratio (LAR), and the homeostasis model assessment (HOMA). Results. Measures of insulin sensitivity were not associated with fasting NEFA levels, but OGIS was strongly associated with NEFA suppression at 30 minutes and strongly inversely associated with IHL. Moreover, LAR was strongly inversely associated with NEFA suppression and strongly associated with IHL. This latter association (beta = 1.11 [1.01, 1.21], P = 0.026) was explained by reduced NEFA suppression (P = 0.24 after adjustment). Conclusions. Impaired postprandial NEFA suppression, but not fasting NEFA, contributes to the strong and well-established association between whole body insulin resistance and liver fat accumulation.

[1]  W. Marsden.  I and J , 2012 .

[2]  K. Nair,et al.  Nonoxidative free fatty acid disposal is greater in young women than men. , 2011, Journal of Clinical Endocrinology and Metabolism.

[3]  D. Savage,et al.  Recent insights into fatty liver, metabolic dyslipidaemia and their links to insulin resistance , 2010, Current opinion in lipidology.

[4]  U. Ekelund,et al.  The effects of aerobic exercise on metabolic risk, insulin sensitivity and intrahepatic lipid in healthy older people from the Hertfordshire Cohort Study: a randomised controlled trial , 2010, Diabetologia.

[5]  M. Walker,et al.  Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals , 2009, Diabetologia.

[6]  F. Karpe,et al.  Adipose tissue fatty acid metabolism in insulin-resistant men , 2008, Diabetologia.

[7]  Norbert Stefan,et al.  Causes and metabolic consequences of Fatty liver. , 2008, Endocrine reviews.

[8]  A. Hakkarainen,et al.  Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects. , 2008 .

[9]  M. Bradbury.  Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[10]  C. Cooper,et al.  Cohort profile: the Hertfordshire cohort study. , 2005, International journal of epidemiology.

[11]  J. Jessurun,et al.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.

[12]  K. Petersen,et al.  Mechanisms of insulin resistance in humans and possible links with inflammation. , 2005, Hypertension.

[13]  S. Grundy,et al.  Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. , 2005, American journal of physiology. Endocrinology and metabolism.

[14]  S. Wild,et al.  Non-esterified fatty acid concentrations are independently associated with hepatic steatosis in obese subjects , 2005, Diabetologia.

[15]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[16]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[17]  G. Shulman,et al.  Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β‐cell dysfunction , 2002, European journal of clinical investigation.

[18]  Andrea Mari,et al.  A Model-Based Method for Assessing Insulin Sensitivity From the Oral Glucose Tolerance Test , 2001 .

[19]  J. Cauley,et al.  Measurement of fat mass using DEXA: a validation study in elderly adults. , 2000, Journal of applied physiology.

[20]  L. Groop,et al.  Free fatty acid and glucose metabolism in human aging: evidence for operation of the Randle cycle. , 1994, The American journal of physiology.

[21]  M. Jensen,et al.  Insulin Regulation of Lipolysis in Nondiabetic and IDDM Subjects , 1989, Diabetes.

[22]  A. Golay,et al.  Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus. , 1987, The Journal of clinical endocrinology and metabolism.

[23]  J C Stanley,et al.  The glucose-fatty acid cycle. Relationship between glucose utilization in muscle, fatty acid oxidation in muscle and lipolysis in adipose tissue. , 1981, British journal of anaesthesia.

[24]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.

[25]  P. J. Randle,et al.  The glucose-fatty-acid cycle. , 1963, Lancet.